The apparent 1.01x P/B discount versus a 1.24-1.58x peer range largely disappears once the $7.83 per share gap between book and tangible book is recognised, suggesting investors should anchor on P/TBV rather than headline P/B when benchmarking ASB against Wintrust or Fulton. A 10.9x trailing P/E and 9.9x forward P/E look inexpensive, but with the 2026Q3 guidance posture skipped and the $0.80 consensus EPS assumption unanchored, the earnings denominator warrants verification before the multiple is treated as a margin of safety. On the reported 0.3% ROA and 11% equity base, the implied return on tangible equity does not obviously clear peer-level returns, so the current pricing may reflect a market that expects normalization rather than a franchise premium.

The DuPont identity here resolves almost entirely through ROA: with equity/assets pinned at 0.11 for six consecutive quarters, the ~0.3% ROA mechanically produces the observed ~2.6% ROE, meaning no leverage-driven tailwind is available to close the gap with peers reporting 10-14% ROE. Because fee income contributed 18.8% of revenue in 2026Q3 versus 16.4% in 2025Q1, the improving mix is doing measurable work in supporting returns, though the swing from the -3.4% fee share in 2024Q4 means year-over-year comparisons remain flattered by base effects. Analysts should note that the ROE figures in this series appear to be reported on a different period basis than the annualized peer ROE figures, so a like-for-like gap requires normalization before concluding ASB is structurally less profitable.

A flat margin alongside the 23.6% year-over-year net interest income growth reported for 2026Q3 indicates volume is generating the revenue while deposit repricing in the core Wisconsin franchise appears to absorb asset-yield gains, which limits upside if funding costs re-accelerate. The efficiency ratio's 470bp improvement over ten quarters is genuine operating leverage and now sits inside peer territory, but the 60.4% print in 2026Q2 shows the trend is not monotonic and may reflect quarter-to-quarter expense timing rather than a settled run-rate. With the securities book expanding sharply and NIM unmoved, investors should monitor whether reinvestment into the $46.3 billion portfolio can contribute spread, because continued margin stagnation would leave the earnings trajectory dependent on expense reduction alone.

Holding equity/assets at 0.11 through a roughly $10 billion asset increase suggests capital has been raised or retained in step with growth, which implies the acquisition was not dilutive to the aggregate equity ratio and that capital deployment capacity exists. However, CET1, Tier 1, and total capital ratios are not provided in this dataset, so the buffer above regulatory minimums cannot be assessed directly and the equity ratio should be treated only as a proxy. The swing from $0.7 million of repurchases in 2026Q2 to $93.0 million in 2026Q3, against a dividend yield that has slipped from 1.0% to 0.7% as the price appreciated, suggests capital return is opportunistic rather than programmatic, and investors should monitor whether a reserve build for commercial real estate would constrain that flexibility.

The valuation discount appears directionally consistent with the return gap: IBCP's 1.54x P/B is underpinned by 14.1% ROE and 10.2% ROIC, whereas ASB's reported profitability metrics do not yet demonstrate comparable earning power, so the discount may be earned rather than undeserved. Whether this gap is structural or cyclical hinges on the flat 0.7% NIM — if deposit franchise stickiness in the Fox River Valley eventually translates into spread expansion, ASB could close toward the 1.2-1.3x cluster occupied by FULT and FHN, but if margin remains compressed the multiple may stay anchored. Peer comparisons also require caution on period conventions, since ASB's 2.6% figure appears to be a quarterly print against annualized peer ROE, and on any measure ASB's 3.1% dividend yield sits above most of the group save Fulton and Independent Bank.